Eledon Pharmaceuticals (ELDN) Other Non Operating Income (2014 - 2026)

Eledon Pharmaceuticals (ELDN) has 12 years of Other Non Operating Income data on file, last reported at $1.1 million in Q1 2026.

• Quarterly Other Non Operating Income fell 20.65% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.8 million (up 31.31% YoY) and the FY2024 annual result came in at $2.8 million, up 190.02% from the prior year.
• Other Non Operating Income rose to $1.1 million in Q1 2026, from $1.0 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $1.4 million in Q1 2025 to a low of -$990000.0 in Q4 2023.
• A 5-year average of $565687.5 and a median of $674500.0 in 2023 frame the typical range for Other Non Operating Income.
• The widest YoY moves for Other Non Operating Income: up 6860.0% in 2023, down 425.66% in 2023.
• Tracing ELDN's Other Non Operating Income over 5 years: stood at $304000.0 in 2022, then tumbled by 425.66% to -$990000.0 in 2023, then jumped by 133.74% to $334000.0 in 2024, then soared by 213.47% to $1.0 million in 2025, then increased by 6.78% to $1.1 million in 2026.
• The last three Other Non Operating Income figures came in at $1.1 million (Q1 2026), $1.0 million (Q3 2025), and $1.2 million (Q2 2025), per Business Quant data.